Showing results (51-60 of 85) with videos related to

Sort By:
Pageof 9
Cancer|May 6, 2021
Incorporation of Patient-Reported Outcomes Measurement Information System to assess quality of life among patients with breast cancer initiating care at an academic centerMadeline B Matthys, Andre M Dempsey, Michelle E Melisko, et al.
Biorxiv : the Preprint Server for Biology|July 10, 2026
CRISPR activation screens identify core protein-dependent regulation of heparan sulfate sulfation and ligand specificityJack C Moore, Haruki Takeuchi, Caitlien Nguyen, et al.
Critical Care Explorations|October 9, 2025
Biomarkers of Microcirculatory Dysfunction in Sepsis: A Pilot Prospective Observational StudyAugust Longino, Katharine Martin, Stephen Bourland, et al.
Seminars in Cancer Biology|February 24, 2021
Disseminated cancer cells in breast cancer: Mechanism of dissemination and dormancy and emerging insights on therapeutic opportunitiesGanesan Ramamoorthi, Krithika Kodumudi, Corey Gallen, et al.
The Journal of Biological Chemistry|September 5, 2025
The Hypoxia-Induced Chromatin Reader ZMYND8 Drives HIF-Dependent Metabolic Rewiring in Breast CancerSandhik Nandi, Atanu Mondal, Ishita Sarkar, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 11, 2013
mChIP-KAT-MS, a method to map protein interactions and acetylation sites for lysine acetyltransferasesLeslie Mitchell, Sylvain Huard, Michael Cotrut, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 12, 2009
Proteome-wide prediction of acetylation substratesAmrita Basu, Kristie L Rose, Junmei Zhang, et al.
Analytical Chemistry|August 6, 2025
Quantitative HILIC-Q-TOF-MS Analysis of Glycosaminoglycans and Non-reducing End Carbohydrate Biomarkers via Glycan Reductive Isotopic LabelingAmrita Basu, Stephanie Archer-Hartmann, Pradeep Chopra, et al.
Journal for Immunotherapy of Cancer|June 16, 2022
Intratumoral delivery of dendritic cells plus anti-HER2 therapy triggers both robust systemic antitumor immunity and complete regression in HER2 mammary carcinomaGanesan Ramamoorthi, Krithika Kodumudi, Colin Snyder, et al.
Frontiers in Immunology|September 3, 2019
Sequential Anti-PD1 Therapy Following Dendritic Cell Vaccination Improves Survival in a HER2 Mammary Carcinoma Model and Identifies a Critical Role for CD4 T Cells in Mediating the ResponseKrithika N Kodumudi, Ganesan Ramamoorthi, Colin Snyder, et al.
Pageof 9